AlSaleh Ayman, AlSaif Shukri M, Alhadramy Osama, Alshehri Mohammed, Al Faraidy Khalid, Almutairi Fawaz, Kinsara Abdulhalim J, Al-Murayeh Mushabab, Ghabashi Abdullah E, Alasnag Mirvat, Hussein Gamal Abdin, Askar Tamer M, Haider Kamel H, Alharbi Ibrahim A, Almokhlef Abdulaziz, Sayed Belal A, Almasswary Adel, Ul-Sabah Zia-, Kazim Hameedullah, Albareda Hazem A, Aldossari Mubarak A, Albawardi Rasha, Alali Rudaynah, Abdulhabeeb Ibrahim A M, Ibrahim Saifeldin Mohamed, Alasmari Sami, Almoghairi Abdulrahman M, Khoja Abdullateef Y, Hussain Naveed, Aminu Balarabe S, Serafi Abdulhalim, Eltayeb Abdalla Osman, BuSaleh Ali Husain, Alsabatien Basel, Hamza Mirghani K, Alsharkawy Rasha, Awwad Awatif A, Mohamed Maha A, Al Habeeb Mohammed A, Shujauddin Syed, Ya'u Jamila Ado, Attia Nashwa M, Kholaif Naji, Bin Ghouth Nazeeh M, Youssef M Kheir I, Qutub Mohammed A, Lawand Samih R, Alkutshan Raed, Ahmed Emadaldein, Basardah Ayman, Alhaj Wasem I, Altaradi Hani, Ali Muhammad, Alqarawi Wael, Alhabib Khalid F
Department of Cardiac Sciences, King Fahad Cardiac Center, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
Saud AlBabtain Cardiac Center (SBCC), Dammam, Eastern Province, Saudi Arabia.
PLoS One. 2025 Sep 2;20(9):e0331215. doi: 10.1371/journal.pone.0331215. eCollection 2025.
The Saudi Acute Myocardial Infarction Registry (STARS) program aims to evaluate the clinical characteristics, management, and outcomes of a representative sample of patients with acute myocardial infarction (AMI) in Saudi Arabia. This second phase evaluates temporal changes in patient care, demographics, and the management benchmarks for AMI.
We created a 5-year recurring, multi-center prospective registry that utilizes a snapshot design in 50 hospitals from various healthcare sectors in Saudi Arabia. The study's recruitment phase spanned from September 3, 2021, to January 6, 2023. During these 16 months, 2,690 patients presenting with acute myocardial infarction (AMI) with or without ST-segment elevation (STEMI or NSTEMI, respectively) were enrolled. The mean age (± SD) of the overall population was 57 (±12.4) years, 70% were Saudi citizens, 82% were men, and (48.8%) of the total patients had STEMI. Fifty-eight percent of patients had diabetes mellitus and 58% had hypertension. Of the total population with STEMI, primary percutaneous coronary intervention (PCI) was performed in 619 patients (47.1%), thrombolytics were given to 584 patients (44.5%), and 110 patients had no reperfusion (8.4%). Among patients who presented within 24 h of symptom onset, the door-to-balloon (DTB) time was 63 min (IQR: 43), with 75.6% achieving DTB < 90 min, whereas the door-to-needle (DTN) was 25 min (IQR: 34), with 57% achieving DTN < 60 min. Thirty-nine percent of patients failed lytic reperfusion and 96% of these required rescue PCI. In 52% of instances, the failure to receive reperfusion therapy was attributed to patients' late presentation. At presentation, only 8.5% of cases were transferred by the Emergency Medical Services. Approximately one-fourth of patients with NSTEMI did not undergo a coronary angiogram. All-cause mortality was 2.4% with no significant difference between sexes or nationalities.
This nationwide AMI registry revealed younger age at presentation with a high prevalence of risk factors for coronary artery disease. While primary PCI key performance indicators have improved from the previous phase, further progress is needed in EMS utilization and acute revascularization for STEMI and NSTEMI.
沙特急性心肌梗死登记(STARS)项目旨在评估沙特阿拉伯急性心肌梗死(AMI)患者代表性样本的临床特征、治疗及预后情况。第二阶段评估患者护理、人口统计学特征以及AMI管理基准的时间变化。
我们创建了一个为期5年的多中心前瞻性重复登记系统,采用快照设计,涵盖沙特阿拉伯不同医疗领域的50家医院。研究招募阶段从2021年9月3日持续至2023年1月6日。在这16个月期间,纳入了2690例有或无ST段抬高(分别为STEMI或NSTEMI)的急性心肌梗死患者。总体人群的平均年龄(±标准差)为57(±12.4)岁,70%为沙特公民,82%为男性,48.8%的患者为STEMI。58%的患者患有糖尿病,58%的患者患有高血压。在STEMI患者总体中,619例(47.1%)接受了直接经皮冠状动脉介入治疗(PCI),584例(44.5%)接受了溶栓治疗,110例(8.4%)未进行再灌注治疗。在症状发作24小时内就诊的患者中,门球时间(DTB)为63分钟(四分位间距:43),75.6%的患者DTB<90分钟,而门针时间(DTN)为25分钟(四分位间距:34),57%的患者DTN<60分钟。39%的患者溶栓再灌注失败,其中96%需要补救性PCI。在52%的情况下,未接受再灌注治疗归因于患者就诊延迟。就诊时,只有8.5%的病例由紧急医疗服务部门转运。约四分之一的NSTEMI患者未进行冠状动脉造影。全因死亡率为2.4%,性别和国籍之间无显著差异。
这项全国性的AMI登记显示,患者就诊年龄较轻,冠状动脉疾病危险因素患病率较高虽然直接PCI的关键绩效指标较上一阶段有所改善,但在紧急医疗服务利用以及STEMI和NSTEMI的急性血运重建方面仍需进一步改进。